Back to Search Start Over

The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper

Authors :
Sergio Pillon
Mariella Catalano
Benjamin Brenner
Zsolt Pecsvarady
Ismail Elalamy
Joseph Lewis
Jean-Claude Wautrecht
D. Olinic
Vincent Maréchal
Mouna Sassi
Isabelle Mahé
Anna Falanga
Nusrat Jabeen
Charles A. Carter
Mary-Paula Colgan
Alexander Makatsariya
Alfonso Tafur
Kasse Aa
Tazi Mezalek Zoubida
Meletios-Athanasios Dimopoulos
Michèle Sabbah
Darko Antic
Yiannis Theodorou
Alex C. Spyropoulos
Vladimir Chekhonin
Meganathan Kannan
Katalin Farkas
Peter Klein-Wegel
Job Harenberg
P Massamba Mbaye
Joseph Gligorov
Manuel Monreal Bosch
Grigoris T. Gerotziafas
Pier Luigi Antignani
Hikmat Abdel-Razeq
James D. Douketis
Gerit Schernthaner
Petros Agathaggelou
Ali T. Taher
Jawed Fareed
Essam Abo Elnazar
Irina Panovska-Stavridis
Patrick Van Dreden
Fabio Leivano
Gerry Fowkes
Fakiha Siddiqui
Mark A. Ligocki
Tishya Indran
Kostantinos Konstantinidis
Bulent Kantarcioglu
Jin Shiomura
Bahare Fazeli
Chryssa Papageorgiou
Yongquan Gu
Anny Slama-Schwok
Eduardo Ramacciotti
Zenguo Zhai
Centre de Recherche Saint-Antoine (CRSA)
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)
CHU Tenon [AP-HP]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)
Università degli Studi di Milano = University of Milan (UNIMI)
Centre d'Immunologie et des Maladies Infectieuses (CIMI)
Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS)
Sechenov First Moscow State Medical University
Campbell University [Buies Creek, NC, USA] (CU)
University of Karachi
Heidelberg University
Università degli Studi di Milano-Bicocca = University of Milano-Bicocca (UNIMIB)
Loyola University [Chicago]
Cyprus Institute (CyI)
University of Belgrade [Belgrade]
Nuova Villa Claudia [Rome, Italy] (NVC)
Universidad Católica San Antonio de Murcia (UCAM)
Rambam Health Care Campus [Haifa, Israel]
Technion - Israel Institute of Technology [Haifa]
Ministry of Health of the Russian Federation (MHRF)
St James's University Hospital
Leeds Teaching Hospitals NHS Trust
Trinity College Dublin
National and Kapodistrian University of Athens (NKUA)
McMaster University [Hamilton, Ontario]
Firestone Institute for Respiratory Health [Hamilton, ON, Canada] (FIRH)
Ministry of Health [Saudi Arabia]
Szent Imre Hospital [Budapest, Hungary] (SIH)
Mashhad University of Medical Sciences
University of Edinburgh
Capital University of Medical Sciences [Beijing] (CUMS)
Hôpitaux Universitaires de l'Est Parisien [Paris] (HUEP)
Monash Medical Centre [Clayton, Australia]
Central University of Tamil Nadu [Thiruvarur, India] (CUTN)
Central University of Tamil Nadu (CUTN)
Okmeydani Training and Research Hospital [Istanbul, Turkey] (OTRH)
Centre International de Cancérologie de Dakar [Dakar, Senegal] (CICD)
Aristotle University of Thessaloniki
University Hospital Southampton NHS Foundation Trust
Université Virtuelle du Sénégal [Dakar, Senegal] (UVS)
Innovations thérapeutiques en hémostase (IThEM - U1140)
Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)
University Clinic of Hematology [Skopje, Republic of North Macedonia] (UCH)
University of Medicine and Pharmacy [Cluj-Napoca, Romania] (UMP)
Service d'Anesthésie réanimation [CHU Tenon]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)
Flor Ferenc Teaching Hospital [Kistarcsa, Hungary] (2FTH)
San Camillo Forlanini Hospital [Rome]
Loyola University Medical Center (LUMC)
Science Valley Research Institute [São Paulo, Brazil] (SVRI)
King Hussein Cancer Center [Amman, Jordan] (KH2C)
CHU Fattouma Bourguiba [Monastir] (HFB)
Medizinische Universität Wien = Medical University of Vienna
Nobelpharma Co. Ltd. [Tokyo, Japan]
Hôpital Erasme [Bruxelles] (ULB)
Faculté de Médecine [Bruxelles] (ULB)
Université libre de Bruxelles (ULB)-Université libre de Bruxelles (ULB)
North Shore University Cardiologists [Skokie, Illinois, USA] (NSUC)
American University of Beirut Faculty of Medicine and Medical Center (AUB)
Klinikum Ernst von Bergmann [Potsdam, Germany] (KEVB)
Peking University [Beijing]
Chinese Academy of Medical Sciences [Beijing, China] (CAMS)
Peking Union Medical College [Beijing, China]
Université Mohammed V de Rabat [Agdal] (UM5)
Scientific Reviewer Committee: Gregory Y H Lip, Michael Makris, Sam Schulman, Wolfgang Siess, Christian Weber
Sabbah, Michèle
Centre de Recherche Saint-Antoine (CR Saint-Antoine)
Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Saint-Antoine [AP-HP]
Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)
University of Milan
Centre d'Immunologie et de Maladies Infectieuses (CIMI)
Università degli Studi di Milano-Bicocca [Milano] (UNIMIB)
Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP)
Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)
University of Mohammed V
Source :
Thrombosis and Haemostasis, Thrombosis and Haemostasis, 2021, 121 (08), pp.992-1007. ⟨10.1055/a-1535-8807⟩, Thrombosis And Haemostasis, r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol, instname, Thrombosis and Haemostasis, Schattauer, 2021, 121 (08), pp.992-1007. ⟨10.1055/a-1535-8807⟩
Publication Year :
2021
Publisher :
HAL CCSD, 2021.

Abstract

Background One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis. Management Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program in many countries in late December 2020 with mRNA vaccines, adenovirus-based vaccines, and inactivated virus vaccines has generated hope for the end of the pandemic. Current Issues The continuous appearance of new pathogenic viral strains and the ability of vaccines to prevent infection and transmission raise important concerns as we try to achieve community immunity against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) and its variants. The need of a second and even third generation of vaccines has already been acknowledged by the WHO and governments. Perspectives There is a critical and urgent need for a balanced and integrated strategy for the management of the COVID-19 outbreaks organized on three axes: (1) Prevention of the SARS-CoV-2 infection, (2) Detection and early diagnosis of patients at risk of disease worsening, and (3) Anticipation of medical care (PDA). Conclusion The “PDA strategy” integrated into state policy for the support and expansion of health systems and introduction of digital organizations (i.e., telemedicine, e-Health, artificial intelligence, and machine-learning technology) is of major importance for the preservation of citizens' health and life world-wide.

Details

Language :
English
ISSN :
03406245
Database :
OpenAIRE
Journal :
Thrombosis and Haemostasis, Thrombosis and Haemostasis, 2021, 121 (08), pp.992-1007. ⟨10.1055/a-1535-8807⟩, Thrombosis And Haemostasis, r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol, instname, Thrombosis and Haemostasis, Schattauer, 2021, 121 (08), pp.992-1007. ⟨10.1055/a-1535-8807⟩
Accession number :
edsair.doi.dedup.....44c581981e7b4e1525fb9e2a8f044aab